ClearSynergy

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: ClearSynergy
Generic name: SALICYLIC ACID
Manufacturer: SRL Enterprises, LLC
Product type: HUMAN OTC DRUG
SPL set ID: b0ad3d4c-7afa-4503-b5d6-c88bf898155e
SPL ID: 23f70c08-1d73-9434-e063-6394a90a1d23
Version: 5
Effective date: 2024-10-08
Source export date: 2026-11-06
Source partition: 7
Source file: https://download.open.fda.gov/drug/label/drug-label-0007-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-11-06/90742968499056f8845d54427ea2950526b02c3f289aedd40679ed8e120a0e89/drug-label-0007-of-0014.json.zip
Source manifest SHA-256: 8dff71fbef1291eb7711013e9a3a06194930757924a8946ae3034107a98d9463
Import run: 20261106T075659Z
Imported at: 2026-11-06 08:41:35

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M006	openfda.application_number
brand name		ClearSynergy	openfda.brand_name
generic name		SALICYLIC ACID	openfda.generic_name
manufacturer name		SRL Enterprises, LLC	openfda.manufacturer_name
ndc	package	71617-102-01	openfda.package_ndc
ndc	product	71617-102	openfda.product_ndc
ndc11	package	71617010201	derived:openfda.package_ndc
rxcui		797885	openfda.rxcui
spl id		23f70c08-1d73-9434-e063-6394a90a1d23	id
spl set id		b0ad3d4c-7afa-4503-b5d6-c88bf898155e	set_id
unii		O414PZ4LPZ	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only. When using this product: Avoid contact with eyes and mouth. If contact occurs, rinse thoroughly with water. Skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one acne medication at a time. Limit use to face and neck.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.